Literature DB >> 7019715

Sequence and specificity of two antibacterial proteins involved in insect immunity.

H Steiner, D Hultmark, A Engström, H Bennich, H G Boman.   

Abstract

Immune responses have been described for many different insect species. However, it is generally acknowledged that immune systems must therefore differ from those of vertebrates. An effective humoral immune response has been found in pupae of the cecropia moth, Hyalophora cecropia. The expression of this multicomponent system requires de novo synthesis of RNA and proteins and its broad antibacterial activity is due to at least three independent mechanisms, the most well known of which is the insect lysozyme. However, this enzyme is bactericidal for only a limited number of Gram-positive bacteria. WE recently purified and characterized P9A and P9B, which are two small, basic proteins with potent antibacterial activity against Escherichia coli and several other Gram-negative bacteria. We believe that P9A and P9B plays an important part in the humoral immune responses described previously and that the P9 proteins represent a new class of antibacterial agents for which we propose the name cecropins. We describe here the primary structures of cecropins A and B. We also show that cecropin A is specific for bacteria in contrast to melittin, the main lytic component in bee venom which lyses both bacteria and eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019715     DOI: 10.1038/292246a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  279 in total

1.  Antibacterial and antimembrane activities of cecropin A in Escherichia coli.

Authors:  L Silvestro; J N Weiser; P H Axelsen
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Crystallization of antimicrobial pores in membranes: magainin and protegrin.

Authors:  L Yang; T M Weiss; R I Lehrer; H W Huang
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines.

Authors:  Louise A Rollins-Smith; Cynthia Carey; J Michael Conlon; Laura K Reinert; Jennifer K Doersam; Tomas Bergman; Jerzy Silberring; Hilkka Lankinen; David Wade
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6.

Authors:  M Frohm Nilsson; B Sandstedt; O Sørensen; G Weber; N Borregaard; M Ståhle-Bäckdahl
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

6.  Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study.

Authors:  Kalpana Bhargava; Jimmy B Feix
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

7.  Modeling the ion channel structure of cecropin.

Authors:  S R Durell; G Raghunathan; H R Guy
Journal:  Biophys J       Date:  1992-12       Impact factor: 4.033

8.  Structure--activity study of the antibacterial peptide fallaxin.

Authors:  Sandra L Nielsen; Niels Frimodt-Møller; Birthe B Kragelund; Paul R Hansen
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

9.  Immobilization of Escherichia coli cells by use of the antimicrobial peptide cecropin P1.

Authors:  Kalvin Gregory; Charlene M Mello
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

10.  Retention of Native Quaternary Structure in Racemic Melittin Crystals.

Authors:  Kathleen W Kurgan; Adam F Kleman; Craig A Bingman; Dale F Kreitler; Bernard Weisblum; Katrina T Forest; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2019-05-06       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.